Cetuximab could be more effective without prior bevacizumab treatment in metastatic colorectal cancer patients

BACKGROUND: Cetuximab and bevacizumab reportedly improve the survival of patients with metastatic colorectal cancer (mCRC), but their most effective sequence of administration is unknown. The aim of this study was to compare the survival of patients with mCRC treated with cetuximab after bevacizumab...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Onco Targets Ther
Huvudupphovsmän: Sato, Yasuyoshi, Matsusaka, Satoshi, Suenaga, Mitsukuni, Shinozaki, Eiji, Mizunuma, Nobuyuki
Materialtyp: Artigo
Språk:Inglês
Publicerad: Dove Medical Press 2015
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4648607/
https://ncbi.nlm.nih.gov/pubmed/26648737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S89241
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk